← All diseases

Genetic syndromes and other conditions

Sturge-Weber syndrome

A disorder of blood vessel development present from birth. There is a red birthmark on the face called a port-wine stain. The brain and eyes may also be affected.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

Orphanet has a guideline for emergency doctors for this disease (language: French, Spanish). See on Orphanet

Prepare an emergency card

This page is translated from the Turkish original.

This disease is followed through the “Genetic syndromes and other conditions” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

Before birth, a change happens in the GNAQ gene in some cells. This change leads to extra blood vessels forming in the skin of the face, the lining of the brain and the eye. Blood flow in the brain may be reduced. How severe the symptoms are varies from person to person.

Which symptoms can occur?

There are three main signs, but not everyone has all of them.

  • A pink-purple port-wine stain on the face (in most)
  • Seizures (fits); they usually begin before the age of 2
  • Temporary weakness on one side of the body
  • Migraine-type headaches
  • Raised pressure inside the eye, called glaucoma
  • Learning or attention problems (sometimes)
  • A tangle of blood vessels in the back layer of the eye (in about a third)

How is it diagnosed?

The diagnosis is considered from the birthmark and the examination. An MRI with contrast is done of the brain. An EEG is done for seizures. Regular eye examinations are needed to check for glaucoma.

Treatment and care

Treatment is aimed at the symptoms. The birthmark can be lightened with laser; several sessions may be needed. Seizures are controlled with medicine and, if needed, surgery. For glaucoma, eye drops or surgery are used. Physiotherapy, special education and lifelong eye follow-up are important. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

It is not inherited. The gene change happens by chance before birth, only in some cells. It is not passed on from the mother and father. Families can talk about their questions in genetic counselling.

Source: MedlinePlus Genetics: Sturge-Weber syndrome · NORD: Sturge Weber Syndrome

Key facts

How is it inherited?
Not inherited
When does it usually start?
Before birth, Newborn period
Gene(s) involved
GNAQ

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Rare disease at school · Telling the school, medicines and emergency plan, inclusion and BEP, support education room, absences, LGS/YKS arrangements, peer bullying.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Sturge-Weber

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 2 active interventional studies for this disease. 1 is recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Genetic syndromes and other conditions: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:3205

No separate ICD-11 code; WHO classifies this disease under: LD23

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.